603658 Autobio Diagnostics
- 45.20
- +0.56+1.25%
Autobio Diagnostics News
Antu Biotech Investor Relations Activity Record Form (November 25, 2024)
Antu Biotech: Antu Biotech\'s announcement on obtaining a medical device registration certificate
Antu Biotech\'s announcement on obtaining a medical device registration certificate
Antu Biotech\'s announcement on the use of idle funds raised for cash management and redemption
Antu Biotech\'s announcement on holding a results briefing for the third quarter of 2024
Antu Biotech Investor Relations Activity Record Form (October 28, 2024)
Antu Biotech\'s progress announcement on the repurchase of the company\'s shares through centralized bidding transactions
Antu Biotech: Legal Opinion on Antu Biotech\'s 2024 3rd Extraordinary General Meeting of Shareholders
Antu Biotech: Antu Biotech\'s announcement on the company\'s senior management remuneration plan
Antu Biotech: Announcement of Resolutions of Antu Biotech\'s 2024 Third Extraordinary General Meeting of Shareholders
Antu Biotech: Announcement of Resolutions of the 1st Meeting of the 5th Board of Supervisors of Antu Biotech
Antu Biotech: Antu Biotech\'s announcement on the completion of the general election of the board of directors and the board of supervisors and the appointment of senior management and securities affairs representatives
Antu Biotech: Announcement of the resolution of the first meeting of the 5th Antu Biotech Board of Directors
Announcement of the resolution of the first meeting of the 5th board of directors of Antu Biotech
Announcement of the resolution of the first meeting of the 5th Board of Supervisors of Antu Biotech
Antu Biotech\'s announcement on the completion of the general election of the board of directors and the board of supervisors and the appointment of senior management and securities affairs representatives
Legal Opinion of Antu Biotech\'s 2024 Third Extraordinary General Meeting of Shareholders
Announcement of Resolutions of Antu Biotech\'s 2024 Third Extraordinary General Meeting of Shareholders
Antu Biotech\'s announcement on the company\'s senior management salary plan
Antu Biotech Report for the Third Quarter of 2024
Analysis
Price Target
No Data
No Data